Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Gains from Investment Securities (2023 - 2025)

Ardent Health (ARDT) has 3 years of Gains from Investment Securities data on record, last reported at -$172000.0 in Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 121.61% year-over-year to -$172000.0; the TTM value through Sep 2025 reached $41.0 million, up 819240.0%, while the annual FY2024 figure was $41.6 million, 7135.3% up from the prior year.
  • Gains from Investment Securities reached -$172000.0 in Q3 2025 per ARDT's latest filing, down from $50000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $40.9 million in Q4 2024 and bottomed at -$743000.0 in Q4 2023.
  • Average Gains from Investment Securities over 3 years is $5.1 million, with a median of -$4000.0 recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: soared 5600.0% in 2024, then tumbled 121.61% in 2025.
  • A 3-year view of Gains from Investment Securities shows it stood at -$743000.0 in 2023, then skyrocketed by 5600.0% to $40.9 million in 2024, then tumbled by 100.42% to -$172000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were -$172000.0 in Q3 2025, $50000.0 in Q2 2025, and $214000.0 in Q1 2025.